Life Sciences

Health insurer’s damages win against AstraZeneca creates new patent risks in The Netherlands

IP owners are liable to be sued by third parties if they assert rights that are subsequently invalidated, rules Dutch court.

Health insurer’s damages win against AstraZeneca creates new patent risks in The Netherlands
Headache relief for high-tech patent owners as working requirements ease in key Asian markets
26 Oct 2020

Headache relief for high-tech patent owners as working requirements ease in key Asian markets

India cuts red tape while Indonesia scraps its system altogether. Both are markets on the rise where compulsory licensing has been a key concern

Group of leading academics say Humira patent thicketing antitrust issues must be looked at again
22 Oct 2020

Group of leading academics say Humira patent thicketing antitrust issues must be looked at again

Professors seek reversal of original district court decision, following the dismissal of a potential landmark dispute over the nature of sham litigation

Latest

View all
26 Oct 2020

French Court of Appeal SPC decision raises validity concerns

Merck IP right fails test in latest Article 3(a) judgment in case that may make France an even more attractive venue for nullity actions Read more

20 Oct 2020

Proposal to waive TRIPS is the latest sign of deepening global IP rifts over covid-19

WHO-backed proposal seeks to suspend key multilateral protections for patents and trade secrets Read more

15 Oct 2020

Despite the praise, there may be less to Moderna’s covid patent pledge than meets the eye

The leading vaccine innovator has won plaudits for its commitment not to enforce its coronavirus-related IP rights against other mRNA inventors Read more

14 Oct 2020

CAFC decision prevents skinny label use, warns dissenting judge

Expect further appeals after majority ruling finds in favour of GSK and makes it easier to prove infringement despite carve outs Read more

News

View all
14 Sep 2020

Changes to Ukraine’s IP laws have major implications for the life sciences

Two recent pieces of legislation have brought the country’s patent system more closely in line with EU rules Read more

12 Sep 2020

It’s the PTAB, stupid

Whether the US chooses four more years of Donald Trump or Joe Biden replaces him, big tech's assault on the PTO shows where the patent policy battle lines are being drawn Read more

5 Sep 2020

Covid-19 shows promise of AI tools – innovators need IP protection, and fast

Breakthroughs by startups across the APAC region show the IP system is working as intended to incentivise innovation - even in a crowded patent landscape Read more

2 Sep 2020

CAFC Illumina clarification is good news for diagnostics innovators

Updated decision increases potential for protecting preparation methods based on natural phenomena under Section 101 Read more

Analysis

View all
8 Oct 2020

The patent system’s social contract has broken down, says IP billionaire Dr Gary Michelson

Spinal surgery pioneer tells IAM that it is important to ensure the US public does not get a rough deal from rights owners Read more

7 Oct 2020

Aon launches potentially game-changing IP financing initiative with $100 million loan to agritech company

“This is the first time you have had the financial industry and the insurance industry come together to create this much capital backed solely by IP,” says CEO Lee Read more

6 Oct 2020

$1.9bn damages verdict against Cisco is the latest in a series of blockbuster wins for US patent owners

So far this year, there have been nine awards of over $100 million handed down by district courts - that's more than the number for 2017, 2018 and 2019 combined Read more

6 Oct 2020

Dividing UPC life sciences division would be a mistake, warns Bracco IP strategy chief

Splitting what should have been the London court’s competencies between Paris and Munich must only be a temporary fix, says Francesco Macchetta Read more

Insights

View all
12 Aug 2020

IP market news highlights

A rundown of some of the top news stories on the IAM platform in May, June and July Read more

12 Aug 2020

As the fallout from covid continues, the two IP superpowers offer different messages

While China cheers an uptick in applications, the USPTO warns of a prolonged downturn Read more

8 Jun 2020

IP Market news highlights

IAM’s biggest spring reads Read more

8 Jun 2020

From French fancy to global community – celebrating 100 issues of IAM 

Founder and editor in chief Joff Wild looks back on 17 years of IAM Read more